NIBR takes a unique approach to pharmaceutical research. At the earliest stages, research priorities are determined by patient need and disease understanding.
At NIBR, physician-scientists are breaking down the boundaries between research and clinical practice.
We use Proof-of-Concept clinical trials (small-scale studies used to get an early read on a drug’s safety and effectiveness) to help us to find and advance the most promising drug candidates.
We believe we can better answer the demand for safer, more effective medicines by keeping our sights on both the science and the patient.
Our model of research – connecting the laboratory to the clinic, and pursuing molecular pathways across a landscape of multiple diseases – means that we have to be a highly collaborative organization.
Every project is made up of cross-functional teams, including pathways scientists, chemists, disease area specialists, clinicians and more.
It is a way of working that has become a part of our research culture.